Why the study?
Tricuspid regurgitation negatively affects outcomes, but surgical intervention carries high operative risk and is not viable for many high-risk patients.
Percutaneous tricuspid valve repair provides an attractive, lower-risk alternative to open heart surgery for high-risk patients with tricuspid regurgitation.
No takes yet. Share an insight, caveat, or question.
Offers potential alternatives for high-risk TR patients; leaves open need for randomized efficacy and safety data.
Mangieri et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: